Quest Diagnostics Q2 earnings exceed estimates, institutional ownership increases to 88.06%.

Quest Diagnostics (NYSE: DGX) has experienced notable changes in institutional ownership, with Clarius Group LLC acquiring 1,353 shares valued at $210,000, and several other investors increasing their stakes. The company's shares opened at $148.67, and it reported Q2 earnings of $2.35 per share, surpassing estimates. Quest announced a quarterly dividend of $0.75, set for October 21. Institutional investors now hold 88.06% of the stock.

October 13, 2024
3 Articles